Eosinophilic esophagitis

References

1. 1.↵
   1. Landres RT,
   2. Kuster GG,
   3. Strum WB.

   Eosinophilic esophagitis in a patient with vigorous achalasia. J Gastroenterol 1978; 74: 1298–1301.

   OpenUrl
2. 2.↵
   1. Yan BM,
   2. Shaffer EA.

   Eosinophilic esophagitis: A newly established cause of dysphagia. World J Gastroenterol 2006; 12: 2328–2334.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Rothenberg ME.

   Biology and treatment of eosinophilic esophagitis. J Gastroenterol 2009; 137: 1238–1249.

   OpenUrl
4. 4.↵
   1. Dellon ES,
   2. Hirano I.

   Epidemiology and natural history of eosinophilic esophagitis. J Gastroenterol 2018; 154: 319–332.e3.

   OpenUrl
5. 5.↵
   1. Dellon ES.

   Eosinophilic esophagitis: diagnostic tests and criteria. Curr Opin Gastroenterol 2012; 28: 382–388.

   OpenUrlPubMed
6. 6.
   1. Dellon ES,
   2. Gonsalves N,
   3. Hirano I,
   4. Furuta GT,
   5. Liacouras CA,
   6. Katzka DA.

   ACG clinical guideline: Evidence based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013; 108: 679–692.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Dhar A,
   2. Haboubi HN,
   3. Attwood SE,
   4. Auth MKH,
   5. Dunn JM,
   6. Sweis R, et al.

   British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic esophagitis in children and adults. Gut 2022; 71: 1459–1487.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Rank MA,
   2. Sharaf RN,
   3. Furuta GT,
   4. Aceves SS,
   5. Greenhawt M,
   6. Spergel JM, et al.

   Technical review on the management of eosinophilic esophagitis: A report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Ann Allergy Asthma Immunol 2020; 124; 424–440.e17.

   OpenUrlPubMed
9. 9.↵
   1. Gonsalves NP,
   2. Aceves SS.

   Diagnosis and treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2020; 145: 1–7.

   OpenUrl
10. 10.↵
    1. Furuta GT,
    2. Katzka DA.

    Eosinophilic esophagitis. N Engl J Med 2015; 373: 1640–1648.

    OpenUrlPubMed
11. 11.↵
    1. Mehta H,
    2. Groetch M,
    3. Wang J.

    Growth and nutritional concerns in children with food allergy. Curr Opin Allergy Clin Immunol 2013; 13: 275–279.

    OpenUrl
12. 12.↵
    1. Blanchard C,
    2. Rothenberg ME.

    Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008; 18: 133–143.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Kim HP,
    2. Vance RB,
    3. Shaheen NJ,
    4. Dellon ES.

    The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: A meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 988–996.e5.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. O’Shea KM,
    2. Aceves SS,
    3. Dellon ES,
    4. Gupta SK,
    5. Spergel JM,
    6. Furuta GT, et al.

    Pathophysiology of eosinophilic esophagitis. J Gastroenterol 2018; 154: 333–345.

    OpenUrl
15. 15.↵
    1. Wechsler JB,
    2. Bolton S,
    3. Amsden K,
    4. Wershil BK,
    5. Hirano I,
    6. Kagalwalla AF.

    Eosinophilic esophagitis reference score accurately identifies disease activity and treatment effects in children. Clin Gastroenterol Hepatol 2018; 16: 1056–1063.

    OpenUrl
16. 16.↵
    1. Dellon ES,
    2. Cotton CC,
    3. Gebhart JH,
    4. Higgins LL,
    5. Beitia RM,
    6. Woosley JT, et al.

    Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment. Clin Gastroenterol Hepatol 2016; 14: 31–39.

    OpenUrlPubMed
17. 17.↵
    1. Rothenberg ME.

    Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. J Gastroenterol 2015; 148: 1143–1157.

    OpenUrl
18. 18.↵
    1. Rieder F,
    2. Nonevski I,
    3. Ma J,
    4. Ouyang Z,
    5. West G,
    6. Protheroe C, et al.

    T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. J Gastroenterol 2014; 146: 1266–1277.e9.

    OpenUrl
19. 19.↵
    1. Ko E,
    2. Chehade M.

    Biological therapies for eosinophilic esophagitis: Where do we stand? Clin Rev Allergy Immunol 2018; 55: 205–216.

    OpenUrl
20. 20.↵
    1. Rothenberg ME,
    2. Wen T,
    3. Greenberg A,
    4. Alpan O,
    5. Enav B,
    6. Hirano I, et al.

    Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2015; 135: 500–507.

    OpenUrlCrossRef
21. 21.↵
    1. Lucendo AJ,
    2. Miehlke S,
    3. Schlag C,
    4. Vieth M,
    5. von Arnim U,
    6. Molina-Infante J, et al.

    Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. J Gastroenterol 2019; 157: 74–86. e15.

    OpenUrl
22. 22.↵
    1. Straumann A,
    2. Lucendo AJ,
    3. Miehlke S,
    4. Vieth M,
    5. Schlag C,
    6. Biedermann L, et al.

    Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis. J Gastroenterol 2020; 159: 1672–1685.

    OpenUrl
23. 23.↵
    1. Dellon ES,
    2. Lucendo AJ,
    3. Schlag C,
    4. Schoepfer AM,
    5. Falk GW,
    6. Eagle G, et al.

    Fluticasone dipropionate orally disintegrating tablet (APT-1011) for eosinophilic esophagitis: randomized controlled trial. Clin Gastroenterol Hepatol 2022; 20: 2485–2494.

    OpenUrl
24. 24.↵
    1. Syverson EP,
    2. Hait E.

    Update on emerging pharmacologic therapies for patients with eosinophilic esophagitis. J Gastroenterol Hepatol 2022; 18: 207–212.

    OpenUrl
25. 25.↵
    1. Dellon ES,
    2. Rothenberg ME,
    3. Collins MH,
    4. Hirano I,
    5. Chehade M,
    6. Bredenoord AJ, et al.

    Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med 2022; 387: 2317–2330.

    OpenUrl
26. 26.↵
    Drugs.com. Dupixent FDA Approval History. [Last updated on Oct 2, 2022; accessed October 2022]. Avalible from https://www.drugs.com/history/dupixent.html.